Align Technology | ALGN - 贷款资金



金融业
股票价格
USD
资产
USD 6.42B
现金及等价物
USD 1.1B
销售成本
USD 298.76M
流动资产
USD 2.66B
流动负债
USD 1.91B
债务
USD 116.04M
EBIT
USD 191.32M
EBITDA
USD 229.14M
员工
20.95K
EPS每股收益
USD 2.64
股本和储备
USD 4.23B
销售毛利
USD 757.43M
债务利息支出
USD 6.93M
利息收入
USD 3.91M
贷款资金
USD 0
市值
USD 13.54B
净收入
USD 108.29M
营业费用
USD 864.87M
营业利润
USD 191.32M
普通股股本
USD 71.62M
PE价格收益
21.81
税前利润
USD 148.69M
销售收入
USD 1.06B
销售和管理费用
USD 462.67M
股票
USD 212.24M
贸易债权人
USD 109.84M
应收帐款人
USD 1.15B


贷款资金 更改 日
3M USD 10.9B 2M 2026-06
Align Technology USD 0 0 2024-12
Becton, Dickinson and Co. USD 13.51B 1.2B 2026-06
Bruker USD 1.81B 151.8M 2026-06
Cardinal Health USD 7B 1.24B 2026-06
Charles River Laboratories USD 2.62B 43.15M 2026-06
Cooper Companies USD 1.86B 17.7M 2026-03
CVS Health USD 59.45B 1.08B 2026-06
Danaher USD 25.15B 7.59B 2026-06
Dentsply International USD 2B 10M 2026-06
Dexcom USD 1.3B 200K 2026-06
Henry Schein USD 2.3B 27M 2026-06
Idexx Laboratories USD 299.86M 11K 2026-06
Insulet USD 929.5M 0 2026-06
Integra LifeSciences USD 1.83B 2.05M 2026-06
IQVIA Holdings USD 13.7B 284M 2026-06
McKesson USD 8.43B 3.17B 2026-06
Mettler Toledo International USD 2.04B 116.92M 2026-06
Revvity USD 2.63B 1.02M 2026-06
Solventum Corp USD 4.57B 2M 2026-06
Stryker USD 14.19B 32M 2026-06
Teleflex USD 2.72B 206.24M 2026-06
Thermo Fisher Scientific USD 39.18B 890M 2026-06
Waters USD 5.09B 129M 2026-06
Zimmer Biomet Holdings USD 6.28B 17.6M 2026-06
Zoetis USD 9.05B 3M 2026-06